(firstQuint)Open-Label Crossover Study Comparing CTP-543 to Jakafi.

 The crossover design will assess the safety, tolerability, PK and metabolite profiles of a single dose of CTP-543 compared to a single dose of Jakafi.

 Approximately 12 healthy volunteers will be enrolled in this open label study.

.

 Open-Label Crossover Study Comparing CTP-543 to Jakafi@highlight

This study will assess the metabolite and pharmacokinetic (PK) profile of a single dose of CTP-543 compared to a single dose of Jakafi(R) in healthy volunteers.

